The term Chronic Kidney Disease Drugs refers to conditions that damage the kidneys and decrease their function
Chronic Kidney
Disease Drugs Market
"Chronic kidney disease drugs are an important public health issue, and there is a significant unmet need for therapies that slow disease progression and improve outcomes." The approval of Farxiga for the treatment of chronic renal disease is a significant step in the right direction for those who are dealing with the condition.
When the kidneys are
injured and unable to properly filter blood, chronic kidney disease develops.
Patients may experience difficulties from fluid, electrolytes (minerals needed
for numerous bodily processes), and waste buildup in the body as a result of
this poor filtering. Renal failure can occasionally result from chronic kidney
disease.
In multicenter, double-blind research, the ability of Farxiga to enhance kidney
outcomes and lower cardiovascular death in patients with Chronic Kidney Disease Drugs Market was assessed.
4,304 participants were randomly randomized to receive either Farxiga or placebo in this research. The trial evaluated the two groups for the number of
patients whose disease proceeded to a composite endpoint, which was defined as
at least a 50% decline in kidney function, progression to kidney failure, or
progression to cardiovascular or renal death.
The
effectiveness of Farmiga in treating Chronic Kidney Disease Drugs Market
in people with autosomal
dominant or recessive polycystic kidney disease, which is characterized by
numerous cysts, or in people who need or have recently taken immunosuppressive
medication to treat renal disease, has not been evaluated.
Patients
who have experienced severe allergic reactions to the drug in the past or who
are receiving dialysis therapy shouldn't use Farxiga. Chronic
Kidney Disease Drugs Market patients taking Farxiga have experienced
serious, life-threatening episodes of Fournier's Gangrene. If a patient is
using Farxiga along with insulin or an insulin secretagogue, they should think
about switching to a lower dose of those medications to lessen their risk of
hypoglycemia (low blood sugar).
Comments
Post a Comment